Literature DB >> 34144102

Peritoneal Dialysis Use in Patients With Ascites: A Review.

Nilum Rajora1, Lucia De Gregorio2, Ramesh Saxena3.   

Abstract

The past few decades have seen steady increase in the prevalence of kidney failure needing kidney replacement therapy. Concomitantly, there has been progressive growth of heart failure and chronic liver disease, and many such patients develop ascites. Therefore, it is not uncommon to encounter patients with kidney failure who concurrently have ascites. The presence of ascites adds many challenges in the management of kidney failure. Poor hemodynamics make volume management difficult. The presence of coagulopathy, malnutrition, and encephalopathy compounds the complexity of the management. Such patients do not tolerate hemodialysis well. However, several concerns have limited the use of peritoneal dialysis (PD), so hemodialysis remains the predominant dialysis modality in these patients. However, observational studies have illustrated that PD provides hemodynamic stability and facilitates better volume management compared with hemodialysis. Moreover, PD obviates the need for therapeutic paracentesis by facilitating continuous drainage of ascites. PD potentially reduces hemorrhagic complications by avoiding routine anticoagulation use. Moreover, small studies have suggested that outcomes such as peritonitis and mechanical complications are comparable to those in PD patients without ascites. PD does not affect transplant candidacy, and these patients can successfully receive combined liver and kidney transplants. Hence, PD should be considered a viable dialysis option in kidney failure patients with ascites.
Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ascites; catheter placement; chronic kidney disease (CKD); chronic liver disease (CLD); cirrhosis; dialysis; dialysis modality; fill volume; hypoalbuminemia; kidney failure; nutritional status; peritoneal dialysis (PD); peritonitis; review; simultaneous kidney and liver transplant (SLKT); volume status

Mesh:

Year:  2021        PMID: 34144102      PMCID: PMC8545758          DOI: 10.1053/j.ajkd.2021.04.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  58 in total

1.  Outcome of peritoneal dialysis in cirrhotic patients with end-stage renal disease: a 24-years' experience in Taiwan.

Authors:  S-T Huang; Y-W Chuang; C-H Cheng; M-J Wu; C-H Chen; T-M Yu; K-H Shu
Journal:  Clin Nephrol       Date:  2011-10       Impact factor: 0.975

Review 2.  Peritoneal dialysis in the comprehensive management of end-stage renal disease patients with liver cirrhosis and ascites: practical aspects and review of the literature.

Authors:  Rafael Selgas; M-Auxiliadora Bajo; Gloria Del Peso; Rafael Sánchez-Villanueva; Elena Gonzalez; Sara Romero; Elena Olivas; Covadonga Hevia
Journal:  Perit Dial Int       Date:  2008 Mar-Apr       Impact factor: 1.756

Review 3.  Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

Authors:  P Y Martin; P Ginès; R W Schrier
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

Review 4.  AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review.

Authors:  Patrick G Northup; Lawrence S Friedman; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-28       Impact factor: 11.382

5.  Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure.

Authors:  Tse-Ling Fong; Saro Khemichian; Tariq Shah; Ian V Hutchinson; Yong W Cho
Journal:  Transplantation       Date:  2012-08-27       Impact factor: 4.939

Review 6.  Interactions of the heart and the liver.

Authors:  Søren Møller; Mauro Bernardi
Journal:  Eur Heart J       Date:  2013-07-12       Impact factor: 29.983

7.  Cerebral oedema and increased intracranial pressure in chronic liver disease.

Authors:  J P Donovan; D F Schafer; B W Shaw; M F Sorrell
Journal:  Lancet       Date:  1998-03-07       Impact factor: 79.321

8.  Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA.

Authors:  Bolin Niu; Brian Kim; Berkeley N Limketkai; Jing Sun; Zhiping Li; Tinsay Woreta; Po-Hung Chen
Journal:  Dig Dis Sci       Date:  2018-02-26       Impact factor: 3.199

9.  Liver cirrhosis leads to poorer survival in patients with end-stage renal disease.

Authors:  Ae Jin Kim; Hye Jin Lim; Han Ro; Ji Yong Jung; Hyun Hee Lee; Wookyung Chung; Jae Hyun Chang
Journal:  Korean J Intern Med       Date:  2016-03-26       Impact factor: 2.884

10.  Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease.

Authors:  Che-Yi Chou; Shu-Ming Wang; Chih-Chia Liang; Chiz-Tzung Chang; Jiung-Hsiun Liu; I-Kuan Wang; Lien-Cheng Hsiao; Chih-Hsin Muo; Chi-Jung Chung; Chiu-Ching Huang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

View more
  2 in total

1.  Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization.

Authors:  Yingfeng Shi; Jinqing Li; Hui Chen; Yan Hu; Lunxian Tang; Xun Zhou; Min Tao; Zexin Lv; Si Chen; Andong Qiu; Na Liu
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

2.  Liver cirrhosis with encapsulating peritoneal sclerosis after 4 years of peritoneal dialysis: A case report.

Authors:  Kanako Watanabe-Kusunoki; Yoshihiro Kusunoki; Junichi Goto; Kazutaka Kukita
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.